{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:23:23Z","timestamp":1760243003895,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.lungcan.2018.11.034","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T13:41:46Z","timestamp":1543498906000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-9361","authenticated-orcid":false,"given":"Licun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Dell'Anno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Lapidot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Sekido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6016-1645","authenticated-orcid":false,"given":"Veronique","family":"Serre-Beinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-0294","authenticated-orcid":false,"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2018.11.034_bib0005","first-page":"1045","article-title":"Renal lesions in acute rheumatic fever","volume":"51","author":"Grishman","year":"1967","journal-title":"Am. J. Pathol."},{"issue":"15","key":"10.1016\/j.lungcan.2018.11.034_bib0010","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.lungcan.2018.11.034_bib0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM198906293202604","article-title":"Asbestos-related diseases","volume":"320","author":"Mossman","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.034_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15020384","article-title":"Australia\u2019s ongoing legacy of asbestos: significant challenges remain even after the complete banning of asbestos almost fifteen years ago","volume":"15","author":"Soeberg","year":"2018","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1289\/ehp.1002285","article-title":"The case for a global ban on asbestos","volume":"118","author":"LaDou","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15030531","article-title":"Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide","volume":"15","author":"Allen","year":"2018","journal-title":"Int. J. Environ. Res. Pub. Health"},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.21147\/j.issn.1000-9604.2017.04.09","article-title":"Epidemiology and trend analysis on malignant mesothelioma in China","volume":"29","author":"Zhao","year":"2017","journal-title":"Chin. J Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/risa.12887","article-title":"Ambient asbestos fiber concentrations and Long-term trends in pleural mesothelioma incidence between Urban and rural areas in the United States (1973-2012)","volume":"38","author":"Glynn","year":"2018","journal-title":"Risk Anal."},{"issue":"18","key":"10.1016\/j.lungcan.2018.11.034_bib0045","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.034_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5761\/atcs.oa.17-00192","article-title":"Is pleurectomy\/Decortication superior to extrapleural pneumonectomy for patients with malignant pleural mesothelioma? A single-institutional experience","volume":"24","author":"Miyazaki","year":"2018","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"10.1016\/j.lungcan.2018.11.034_bib0055","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","article-title":"National cancer database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma","volume":"12","author":"Verma","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.11.034_bib0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.21037\/atm.2017.03.41","article-title":"The impact of surgical approach on quality of life for pleural malignant mesothelioma","volume":"5","author":"Schwartz","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"24 Suppl","key":"10.1016\/j.lungcan.2018.11.034_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/fon.15.225","article-title":"Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?","volume":"11","author":"Treasure","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.lungcan.2018.11.034_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke","year":"2015","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating surgery for mesothelioma after radiation therapy: the \"SMART\" approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.034_bib0080","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ejcts\/ezw074","article-title":"Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?","volume":"50","author":"Mordant","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"9","key":"10.1016\/j.lungcan.2018.11.034_bib0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and New frontiers in mesothelioma therapeutics","volume":"13","author":"Mutti","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2018.11.034_bib0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jtho.2018.02.021","article-title":"Progress in the management of malignant pleural mesothelioma in 2017","volume":"13","author":"McCambridge","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.11.034_bib0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2016.09.003","article-title":"Imaging in pleural mesothelioma: A review of the 13th International Conference of the International mesothelioma interest group","volume":"101","author":"Armato","year":"2016","journal-title":"Lung Cancer"},{"issue":"20","key":"10.1016\/j.lungcan.2018.11.034_bib0105","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2018.11.034_bib0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12885-015-1953-y","article-title":"Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma","volume":"15","author":"Robinson","year":"2015","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/j.lungcan.2018.11.034_bib0115","doi-asserted-by":"crossref","first-page":"R1173","DOI":"10.1016\/j.cub.2017.07.026","article-title":"Mesothelioma: identical routes to malignancy from asbestos and carbon nanotubes","volume":"27","author":"Port","year":"2017","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.11.034_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1539\/joh.17-0102-RA","article-title":"Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment","volume":"60","author":"Fukushima","year":"2018","journal-title":"J. Occup. Health"},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2018.11.034_bib0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-beta synergizes with defects in the hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J. Exp. Med."},{"issue":"49","key":"10.1016\/j.lungcan.2018.11.034_bib0140","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/onc.2012.5","article-title":"YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes","volume":"31","author":"Mizuno","year":"2012","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040090","article-title":"Targeting the hippo pathway Is a New potential therapeutic modality for malignant mesothelioma","volume":"10","author":"Sekido","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.lungcan.2018.11.034_bib0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0962-8924(01)02071-2","article-title":"Ran GTPase: a master regulator of nuclear structure and function during the eukaryotic cell division cycle?","volume":"11","author":"Clarke","year":"2001","journal-title":"Trends Cell. Biol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0155","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1016\/S0960-9822(01)00132-4","article-title":"Ran GTPase cycle: oOne mechanism -- two functions","volume":"11","author":"Melchior","year":"2001","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/cells4030406","article-title":"Spatiotemporal regulation of nuclear transport machinery and microtubule organization","volume":"4","author":"Okada","year":"2015","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0955-0674(03)00046-2","article-title":"The small GTPase Ran: interpreting the signs","volume":"15","author":"Quimby","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"issue":"Pt 7","key":"10.1016\/j.lungcan.2018.11.034_bib0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1242\/jcs.113.7.1111","article-title":"The ran decathlon: multiple roles of Ran","volume":"113","author":"Sazer","year":"2000","journal-title":"J. Cell. Sci."},{"issue":"8","key":"10.1016\/j.lungcan.2018.11.034_bib0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cub.2006.03.056","article-title":"HURP is part of a Ran-dependent complex involved in spindle formation","volume":"16","author":"Koffa","year":"2006","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.11.034_bib0180","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/0008-5472.CAN-07-5279","article-title":"Tumor cell dependence on Ran-GTP-directed mitosis","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.lungcan.2018.11.034_bib0185","doi-asserted-by":"crossref","first-page":"R466","DOI":"10.1016\/j.cub.2006.05.032","article-title":"Cell biology: Ran, mitosis and the cancer connection","volume":"16","author":"Sanderson","year":"2006","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.11.034_bib0190","first-page":"157","article-title":"Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells","volume":"18","author":"Sheng","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.lungcan.2018.11.034_bib0195","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/ijc.23400","article-title":"High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma","volume":"122","author":"Abe","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2018.11.034_bib0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11523-016-0432-y","article-title":"Overexpression of Ran GTPase components regulating nuclear export, but not mitotic spindle assembly, Marks chromosome instability and poor prognosis in breast cancer","volume":"11","author":"Vaidyanathan","year":"2016","journal-title":"Target Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.034_bib0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3727\/096504013X13747716581417","article-title":"Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway","volume":"21","author":"Ning","year":"2013","journal-title":"Oncol. Res."},{"issue":"46","key":"10.1016\/j.lungcan.2018.11.034_bib0210","doi-asserted-by":"crossref","first-page":"75854","DOI":"10.18632\/oncotarget.12420","article-title":"Ran GTPase promotes cancer progression via met recepto-rmediated downstream signaling","volume":"7","author":"Yuen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.11.034_bib0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mrfmmm.2014.11.002","article-title":"Expression status of candidate genes in mesothelioma tissues and cell lines","volume":"771","author":"Melaiu","year":"2015","journal-title":"Mutat Res."},{"issue":"19","key":"10.1016\/j.lungcan.2018.11.034_bib0220","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/j.1742-4658.2010.07799.x","article-title":"Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis","volume":"277","author":"Barash","year":"2010","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.034_bib0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-011-0082-7","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"Vlodavsky","year":"2012","journal-title":"Cancer Microenviron."},{"issue":"8","key":"10.1016\/j.lungcan.2018.11.034_bib0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0968-0004(00)01619-4","article-title":"Heparanase, a potential regulator of cell-matrix interactions","volume":"25","author":"Dempsey","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lungcan.2018.11.034_bib0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","article-title":"Heparanase: from basic research to therapeutic applications in cancer and inflammation","volume":"29","author":"Vlodavsky","year":"2016","journal-title":"Drug. Resist. Updat"},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","article-title":"Mammalian heparanase: what is the message?","volume":"11","author":"Vreys","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lungcan.2018.11.034_bib0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2014.00195","article-title":"The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics","volume":"4","author":"Hammond","year":"2014","journal-title":"Front Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2018.11.034_bib0250","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.11.034_bib0255","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc-2016-0012","article-title":"Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases","volume":"8","author":"Rivara","year":"2016","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.lungcan.2018.11.034_bib0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0265","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2018.11.034_bib0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071881","article-title":"Experimental model of human malignant mesothelioma in athymic mice","volume":"19","author":"Colin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5126","key":"10.1016\/j.lungcan.2018.11.034_bib0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/217370a0","article-title":"Absence of thymus in a mouse mutant","volume":"217","author":"Pantelouris","year":"1968","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lungcan.2018.11.034_bib0285","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1173299","article-title":"Murine mesothelioma induces locally-proliferating IL-10(+)TNF-alpha(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy","volume":"5","author":"Jackaman","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lungcan.2018.11.034_bib0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-018-0411-0","article-title":"USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2\/TRAF3 complex formation","author":"Lu","year":"2018","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0295","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ncb3371","article-title":"Suppression of microRNA activity amplifies IFN-gamma-induced macrophage activation and promotes anti-tumour immunity","volume":"18","author":"Baer","year":"2016","journal-title":"Nat. Cell. Biol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0300","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11626-015-9885-z","article-title":"Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line","volume":"51","author":"Blum","year":"2015","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"3","key":"10.1016\/j.lungcan.2018.11.034_bib0305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","article-title":"Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach","volume":"95","author":"Zeisberger","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.11.034_bib0310","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12885-018-4354-1","article-title":"Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma","volume":"18","author":"Wu","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0315","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/1078-0432.CCR-15-0183","article-title":"Molecular pathways: targeting cancer stem cells awakened by chemotherapy to abrogate tumor repopulation","volume":"22","author":"Chan","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.034_bib0320","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1535-7163.MCT-07-0579","article-title":"Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma","volume":"7","author":"Miselis","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.lungcan.2018.11.034_bib0325","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/2326-6066.CIR-16-0309","article-title":"Depletion of tumor-associated macrophages with a CSF-1R kinase inhibitor enhances antitumor immunity and survival induced by DC immunotherapy","volume":"5","author":"Dammeijer","year":"2017","journal-title":"Cancer Immunol. Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021830672X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021830672X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:26:06Z","timestamp":1759235166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950021830672X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":65,"alternative-id":["S016950021830672X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.034","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}